SCHEMBL525668

SCHEMBL525668

CCOC(=O)CCC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethane SCHEMBL27723238 0.98 CYP1A2 (0.48)
Acrylic Acid SCHEMBL27777947 0.88 CYP1A2 (0.41)
SCHEMBL11399358 0.87 NR1I2 (0.51)
SCHEMBL11399361 0.87 NR1I2 (0.51)
SCHEMBL11301330 0.87 NR1I2 (0.51)
Methacrylic Acid SCHEMBL28783236 0.87 MGAM (0.43)
SCHEMBL3964566 0.86 NR1I2 (0.59)
O-Xylene SCHEMBL27482669 0.85 CYP4F2 (0.49)
SCHEMBL1306604 0.85 TSHR (0.59)
SCHEMBL9183882 0.83 NR1I2 (0.60)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 604 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114570376-A Catalyst for synthesizing menthone and method for synthesizing menthone 安徽海华科技集团有限公司 2022-06-03 CN claimed
CN-107580596-B Sulfimidoylpurine ketone compounds and derivatives for the treatment and prevention of viral infections 豪夫迈·罗氏有限公司 2020-07-14 CN claimed
US-20200109144-A1 Sulfonimidoylpurinone Compounds HOFFMANN-LA ROCHE INC. (US) 2020-04-09 US claimed
CN-109761912-A A kind of synthetic method of polysubstituted pyrimidine derivative 安徽诺全药业有限公司 2019-05-17 CN claimed
EP-3294740-A1 NOVEL SULFONIMIDOYLPURINONE COMPOUNDS AND DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION H. Hoffnabb-La Roche Ag (CH) 2018-03-21 EP claimed
US-20170275286-A1 Novel Sulfonimidoylpurinone Compounds and Derivatives for the Treatment and Prophylaxis of Virus Infection HOFFMANN-LA ROCHE INC. (US) 2017-09-28 US claimed
WO-2016180695-A1 NOVEL SULFONIMIDOYLPURINONE COMPOUNDS AND DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2016-11-17 WO claimed
US-20160326177-A1 Novel Sulfonimidoylpurinone Compounds and Derivatives for the Treatment and Prophylaxis of Virus Infection HOFFMANN-LA ROCHE INC. (US) 2016-11-10 US claimed
EP-2598504-B1 PROCESS FOR THE PREPARATION OF DIMIRACETAM NEUROTUNE AG (CH) 2014-04-16 EP claimed
US-8476453-B2 Process for the preparation of dimiracetam NEUROTUNE AG (CH) 2013-07-02 US claimed
EP-0628638-A2 Process for preparing 2-amino-3-hydroxy acids ELI LILLY AND COMPANY (US) 1994-12-14 EP claimed
WO-1994025459-A1 HETEROCYCLIC DERIVATIVES ZENECA LIMITED (GB) 1994-11-10 WO claimed
WO-1990004393-A1 PRODRUGS OF ANTIINFLAMMATORY 3-ACYL-2-OXINDOLE-1-CARBOXAMIDES PFIZER INC. (US) 1990-05-03 WO claimed
EP-0365194-A2 Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides PFIZER INC. (US) 1990-04-25 EP claimed
EP-0132851-B1 5-SUBSTITUTED(1,2,4)TRIAZOLO(1,5-C)PYRIMIDIN-2-AMINES AMERICAN CYANAMID COMPANY (US) 1989-10-04 EP claimed
EP-0132851-A1 5-Substituted(1,2,4)triazolo(1,5-c)pyrimidin-2-amines AMERICAN CYANAMID COMPANY (US) 1985-02-13 EP claimed
US-4474768-A N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor PFIZER INC. (US) 1984-10-02 US claimed
EP-0101186-A1 N-methyl 11-aza-10-deoxo-10-dihydroerythromycin A, intermediates therefor and processes for their preparation PFIZER INC. (US) 1984-02-22 EP claimed
EP-0037241-A1 Process for the preparation of erythromycylamine 11,12-carbonate PFIZER INC. (US) 1981-10-07 EP claimed
US-4283527-A ANTIBACTERIAL AGENTS PFIZER INC. (US) 1981-08-11 US claimed